Japan’s OTC Market Rebounds On Brisk Lifestyle-Illness Drug Sales
This article was originally published in PharmAsia News
Executive Summary
TOKYO - While Japan's $70 billion pharmaceutical market is shrinking in value in line with the annual lowering of government health insurance drug prices, one sector is registering growth that industry officials describe as rather unexpected: the over-the-counter market for drugs that treat common colds to traditional Chinese medicines for metabolic syndrome